Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 26, 2023 - Issue 5
258
Views
1
CrossRef citations to date
0
Altmetric
Review Articles

The role of myo-inositol supplement in assisted reproductive techniques

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1044-1060 | Received 15 May 2021, Accepted 20 Oct 2021, Published online: 22 Jun 2022

References

  • Abdolsamadi, M., Mohammadi, F., Nashtaei, M. S., Teimouri, M., Sardar, R., Dayani, M., Haghighi, M., Ghasemi, S., Vatannejad, A., & Zandieh, Z. (2020). Does myoinositol supplement improve sperm parameters and DNA integrity in patients with oligoasthenoteratozoospermia after the freezing-thawing process? Cell and Tissue Banking, 21(1), 99–106. https://doi.org/10.1007/s10561-019-09801-7
  • Agarwal, A., Makker, K., & Sharma, R. (2008). Clinical relevance of oxidative stress in male factor infertility: An update. American Journal of Reproductive Immunology, 59(1), 2–11. https://doi.org/10.1111/j.1600-0897.2007.00559.x
  • Agarwal, A., Prabakaran, S. A., & Said, T. M. (2005). Prevention of oxidative stress injury to sperm. Journal of Andrology, 26(6), 654–660. https://doi.org/10.2164/jandrol.05016
  • Akbari Sene, A., Tabatabaie, A., Nikniaz, H., Alizadeh, A., Sheibani, K., Mortezapour Alisaraie, M., Tabatabaie, M., Ashrafi, M., & Amjadi, F. (2019). The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: A randomized clinical trial. Archives of Gynecology and Obstetrics, 299(6), 1701–1707. https://doi.org/10.1007/s00404-019-05111-1
  • Antony, P. J., Gandhi, G. R., Stalin, A., Balakrishna, K., Toppo, E., Sivasankaran, K., Ignacimuthu, S., & Al-Dhabi, N. A. (2017). Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 88, 1098–1113. https://doi.org/10.1016/j.biopha.2017.01.170
  • Avazeri, N., Courtot, A.-M., Pesty, A., Duquenne, C., & Lefevre, B. (2000). Cytoplasmic and nuclear phospholipase C-beta 1 relocation: Role in resumption of meiosis in the mouse oocyte. Molecular Biology of the Cell, 11(12), 4369–4380. https://doi.org/10.1091/mbc.11.12.4369
  • Bar-Oz, B., Koren, G., Nguyen, P., & Kapur, B. M. (2008). Folate fortification and supplementation-are we there yet? Reproductive Toxicology, 25(4), 408–412. https://doi.org/10.1016/j.reprotox.2008.04.010
  • Battaglia, C., Mancini, F., Persico, N., Zaccaria, V., & de Aloysio, D. (2004). Ultrasound evaluation of PCO, PCOS and OHSS. Reproductive Biomedicine Online, 9(6), 614–619. https://doi.org/10.1016/S1472-6483(10)61770-1
  • Beemster, P., Groenen, P., & Steegers-Theunissen, R. (2002). Involvement of inositol in reproduction. Nutrition Reviews, 60(3), 80–87. https://doi.org/10.1301/00296640260042748
  • Benelli, E., Del Ghianda, S., Di Cosmo, C., & Tonacchera, M. (2016). A combined therapy with myo-inositol and D-chiro-inositol improves endocrine parameters and insulin resistance in PCOS young overweight women. International Journal of Endocrinology, 2016, 3204083. https://doi.org/10.1155/2016/3204083
  • Berridge, M. J., & Irvine, R. F. (1984). Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature, 312(5992), 315–321. https://doi.org/10.1038/312315a0
  • Best, M. D., Zhang, H., & Prestwich, G. D. (2010). Inositol polyphosphates, diphosphoinositol polyphosphates and phosphatidylinositol polyphosphate lipids: Structure, synthesis, and development of probes for studying biological activity. Natural Product Reports, 27(10), 1403–1430. https://doi.org/10.1039/b923844c
  • Bevilacqua, A., Carlomagno, G., Gerli, S., Montanino Oliva, M., Devroey, P., Lanzone, A., Soulange, C., Facchinetti, F., Carlo Di Renzo, G., Bizzarri, M., Hod, M., Cavalli, P., D’Anna, R., Benvenga, S., Chiu, T. T., & Kamenov, Z. A. (2015). Results from the international consensus conference on myo-inositol and D-chiro-inositol in obstetrics and gynecology-assisted reproduction technology. Gynecological Endocrinology, 31(6), 441–446. https://doi.org/10.3109/09513590.2015.1006616
  • Beygi, Z., Forouhari, S., Mahmoudi, E., Hayat, S., & Nourimand, F. (2021). Role of oxidative stress and antioxidant supplementation in male fertility. Current Molecular Medicine, 21(4), 265–282. https://doi.org/10.2174/1566524020999200831123553
  • Bizzarri, M., & Carlomagno, G. (2014). Inositol: History of an effective therapy for polycystic ovary syndrome. European Review for Medical and Pharmacological Sciences, 18(13), 1896–1903. https://www.europeanreview.org/article/7565
  • Calogero, A., Gullo, G., La Vignera, S., Condorelli, R., & Vaiarelli, A. (2015). Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: A prospective double-blind randomized placebo-controlled study. Andrology, 3(3), 491–495. https://doi.org/10.1111/andr.12025
  • Canepa, P., Dal Lago, A., De Leo, C., Gallo, M., Rizzo, C., Licata, E., Anserini, P., Rago, R., & Scaruffi, P. (2018). Combined treatment with myo-inositol, alpha-lipoic acid, folic acid and vitamins significantly improves sperm parameters of sub-fertile men: A multi-centric study. European Review for Medical and Pharmacological Sciences, 22, 7078–7085 https://doi.org/10.26355/eurrev_201810_16180
  • Carlomagno, G., Nordio, M., Chiu, T., & Unfer, V. (2011). Contribution of myo-inositol and melatonin to human reproduction. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 159(2), 267–272. https://doi.org/10.1016/j.ejogrb.2011.07.038
  • Cavalli, P., Tedoldi, S., & Riboli, B. (2008). Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs. Birth Defects Research. Part A, Clinical and Molecular Teratology, 82(7), 540–542. https://doi.org/10.1002/bdra.20454
  • Chau, J. F., Lee, M., Law, J. W., Chung, S. K., & Chung, S. S. (2005). Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves . FASEB Journal, 19(13), 1887–1889. https://doi.org/10.1096/fj.05-4192fje
  • Chauvin, T. R., & Griswold, M. D. (2004). Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium. Biology of Reproduction, 70(3), 744–751. https://doi.org/10.1095/biolreprod.103.022731
  • Chiu, T. T., Rogers, M. S., Law, E. L., Briton-Jones, C. M., Cheung, L., & Haines, C. J. (2002). Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: Relationship with oocyte quality. Human Reproduction, 17(6), 1591–1596. https://doi.org/10.1093/humrep/17.6.1591
  • Chiu, T. T., & Tam, P. P. (1992). A correlation of the outcome of clinical in vitro fertilization with the inositol content and embryotrophic properties of human serum. Journal of Assisted Reproduction and Genetics, 9(6), 524–530. https://doi.org/10.1007/BF01204248
  • Chiu, T. T. Y., Rogers, M. S., Briton‐Jones, C., & Haines, C. (2003). Effects of myo‐inositol on the in‐vitro maturation and subsequent development of mouse oocytes. Human Reproduction, 18(2), 408–416. https://doi.org/10.1093/humrep/deg113
  • Colazingari, S., Fiorenza, M. T., Carlomagno, G., Najjar, R., & Bevilacqua, A. (2014). Improvement of mouse embryo quality by myo-inositol supplementation of IVF media. Journal of Assisted Reproduction and Genetics, 31(4), 463–469. https://doi.org/10.1007/s10815-014-0188-1
  • Colazingari, S., Treglia, M., Najjar, R., & Bevilacqua, A. (2013). The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: Results from a randomized controlled trial. Archives of Gynecology and Obstetrics, 288(6), 1405–1411. https://doi.org/10.1007/s00404-013-2855-3
  • Condorelli, R., La Vignera, S., Di Bari, F., Unfer, V., & Calogero, A. (2011). Effects of myoinositol on sperm mitochondrial function in-vitro. European Review for Medical and Pharmacological Sciences, 15(2), 129–134.
  • Condorelli, R., La Vignera, S., Mongioì, L., Vitale, S., Laganà, A., Cimino, L., & Calogero, A. (2017). Myo-inositol as a male fertility molecule: Speed them up. European Review for Medical and Pharmacological Sciences, 21(2 Suppl), 30–35. https://www.europeanreview.org/article/12993
  • Condorelli, R. A., La Vignera, S., Bellanca, S., Vicari, E., & Calogero, A. E. (2012). Myoinositol: Does it improve sperm mitochondrial function and sperm motility? Urology, 79(6), 1290–1295. https://doi.org/10.1016/j.urology.2012.03.005
  • Costantino, D., Minozzi, G., Minozzi, E., & Guaraldi, C. (2009). Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: A double-blind trial. European Review for Medical and Pharmacological Sciences, 13(2), 105–110. https://www.europeanreview.org/article/604
  • D’Anna, R., Di Benedetto, V., Rizzo, P., Raffone, E., Interdonato, M. L., Corrado, F., & Di Benedetto, A. (2012). Myo-inositol may prevent gestational diabetes in PCOS women. Gynecological Endocrinology, 28(6), 440–442. https://doi.org/10.3109/09513590.2011.633665
  • Di Paolo, G., & De Camilli, P. (2006). Phosphoinositides in cell regulation and membrane dynamics. Nature, 443(7112), 651–657. https://doi.org/10.1038/nature05185
  • Di Renzo, G., Anceschi, M., & Cosmi, E. (1989). Lung surfactant enhancement in utero. European Journal of Obstetrics & Gynecology and Reproductive Biology, 32(1), 1–11. https://doi.org/10.1016/0028-2243(89)90115-9
  • Dinkova, A., Martinov, D., & Konova, E. (2017). Efficacy of myo-inositol in the clinical management of patients with asthenozoospermia. European Review for Medical and Pharmacological Sciences, 21(2 Suppl), 62–65. https://www.europeanreview.org/article/12302
  • Downes, C. P., & Macphee, C. H. (1990). Myo-inositol metabolites as cellular signals. European Journal of Biochemistry, 193(1), 1–18. https://doi.org/10.1111/j.1432-1033.1990.tb19297.x
  • Dutta, S., Majzoub, A., & Agarwal, A. (2019). Oxidative stress and sperm function: A systematic review on evaluation and management. Arab Journal of Urology, 17(2), 87–97. https://doi.org/10.1080/2090598X.2019.1599624
  • Ertzeid, G., & Storeng, R. (2001). The impact of ovarian stimulation on implantation and fetal development in mice. Human Reproduction, 16(2), 221–225. https://doi.org/10.1093/humrep/16.2.221
  • Facchinetti, F., Bizzarri, M., Benvenga, S., D’Anna, R., Lanzone, A., Soulage, C., Di Renzo, G. C., Hod, M., Cavalli, P., Chiu, T. T., Kamenov, Z. A., Bevilacqua, A., Carlomagno, G., Gerli, S., Oliva, M. M., & Devroey, P. (2015). Results from the international consensus conference on myo-inositol and D-chiro-inositol in obstetrics and gynecology: The link between metabolic syndrome and PCOS. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 195, 72–76. https://doi.org/10.1016/j.ejogrb.2015.09.024
  • Facchinetti, F., Espinola, M., Dewailly, D., Ozay, A. C., Prapas, N., Vazquez-Levin, M., Wdowiak, A., & Unfer, V. (2020). Breakthroughs in the use of inositols for assisted reproductive treatment (ART). Trends in Endocrinology and Metabolism: TEM, 31(8), 570–579. https://doi.org/10.1016/j.tem.2020.04.003
  • Fiorenza, M., Torcia, S., Canterini, S., Bevilacqua, A., Narducci, M., Ragone, G., Croce, C. M., Russo, G., & Mangia, F. (2008). TCL1 promotes blastomere proliferation through nuclear transfer, but not direct phosphorylation, of AKT/PKB in early mouse embryos. Cell Death and Differentiation, 15(2), 420–422. https://doi.org/10.1038/sj.cdd.4402228
  • Gardner, D. K., Reed, L., Linck, D., Sheehan, C., & Lane, M. (2005). Quality control in human in vitro fertilization. Seminars in Reproductive Medicine, 23(4), 319–324. https://doi.org/10.1055/s-2005-923389
  • Gerli, S., Papaleo, E., Ferrari, A., & Di Renzo, G. (2007). Randomized, double blind placebo-controlled trial: Effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. European Review for Medical and Pharmacological Sciences, 11(5), 347–354. https://www.europeanreview.org/article/458
  • Ghasemi, A., Amjadi, F., Masoumeh Ghazi Mirsaeed, S., Mohammad Beigi, R., Ghasemi, S., Moradi, Y., & Tahereh Ghazi Mirsaeed, S. (2019). The effect of myo-inositol on sperm parameters and pregnancy rate in oligoasthenospermic men treated with IUI: A randomized clinical trial. International Journal of Reproductive Biomedicine, 17(10), 749–756. https://doi.org/10.18502/ijrm.v17i10.5296
  • Giordano, D., Corrado, F., Santamaria, A., Quattrone, S., Pintaudi, B., Di Benedetto, A., & D’Anna, R. (2011). Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: A perspective, randomized, placebo-controlled study. Menopause, 18(1), 102–104. https://doi.org/10.1097/gme.0b013e3181e8e1b1
  • Goud, P. T., Goud, A. P., Leybaert, L., Oostveldt, P. V., Mikoshiba, K., Diamond, M. P., & Dhont, M. (2002). Inositol 1,4,5-trisphosphate receptor function in human oocytes: Calcium responses and oocyte activation-related phenomena induced by photolytic release of InsP(3) are blocked by a specific antibody to the type I receptor. Molecular Human Reproduction, 8(10), 912–918. https://doi.org/10.1093/molehr/8.10.912
  • Governini, L., Ponchia, R., Artini, P. G., Casarosa, E., Marzi, I., Capaldo, A., Luddi, A., & Piomboni, P. (2020). Respiratory mitochondrial efficiency and DNA oxidation in human sperm after in vitro myo-inositol treatment. Journal of Clinical Medicine, 9(6), 1638. https://doi.org/10.3390/jcm9061638
  • Gulino, F. A., Leonardi, E., Marilli, I., Musmeci, G., Vitale, S. G., Leanza, V., & Palumbo, M. A. (2016). Effect of treatment with myo-inositol on semen parameters of patients undergoing an IVF cycle: In vivo study. Gynecological Endocrinology, 32(1), 65–68. https://doi.org/10.3109/09513590.2015.1080680
  • Hallman, M., Feldman, B. H., Kirkpatrick, E., & Gluck, L. (1977). Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns. Pediatric Research, 11(6), 714–720. https://doi.org/10.1203/00006450-197706000-00003
  • Heimark, D., McAllister, J., & Larner, J. (2014). Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocrine Journal, 61(2), 111–117. https://doi.org/10.1507/endocrj.ej13-0423
  • Higgins, B., & Kane, M. (2003). Inositol transport in mouse oocytes and preimplantation embryos: Effects of mouse strain, embryo stage, sodium and the hexose transport inhibitor, phloridzin. Reproduction, 125(1), 111–118. https://doi.org/10.1530/rep.0.1250111
  • Ho, H.-C., & Suarez, S. S. (2003). Characterization of the intracellular calcium store at the base of the sperm flagellum that regulates hyperactivated motility. Biology of Reproduction, 68(5), 1590–1596. https://doi.org/10.1095/biolreprod.102.011320
  • Homa, S. T. (1991). Neomycin, an inhibitor of phosphoinositide hydrolysis, inhibits the resumption of bovine oocyte spontaneous meiotic maturation. The Journal of Experimental Zoology, 258(1), 95–103. https://doi.org/10.1002/jez.1402580111
  • Homburg, R. (1996). Polycystic ovary syndrome – From gynaecological curiosity to multisystem endocrinopathy. Human Reproduction, 11(1), 29–39. https://doi.org/10.1093/oxfordjournals.humrep.a019031
  • Hourvitz, A., Machtinger, R., Maman, E., Baum, M., Dor, J., & Levron, J. (2009). Assisted reproduction in women over 40 years of age: How old is too old? Reproductive BioMedicine Online, 19(4), 599–603. https://doi.org/10.1016/j.rbmo.2009.04.002
  • Huang, L., Fonteles, M., Houston, D., Zhang, C., & Larner, J. (1993). Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology, 132(2), 652–657. https://doi.org/10.1210/endo.132.2.8425485
  • Indyk, H. E., & Woollard, D. C. (1994). Determination of free myo-inositol in milk and infant formula by high-performance liquid chromatography. The Analyst, 119(3), 397–402. https://doi.org/10.1039/an9941900397
  • Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R., Elixson, M., Warnes, C. A., & Webb, C. L. (2007). Noninherited risk factors and congenital cardiovascular defects: Current knowledge: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation, 115(23), 2995–3014. https://doi.org/10.1161/CIRCULATIONAHA.106.183216
  • Jesch, S. A., Zhao, X., Wells, M. T., & Henry, S. A. (2005). Genome-wide analysis reveals inositol, not choline, as the major effector of Ino2p-Ino4p and unfolded protein response target gene expression in yeast. The Journal of Biological Chemistry, 280(10), 9106–9118. https://doi.org/10.1074/jbc.M411770200
  • Kamenov, Z., Kolarov, G., Gateva, A., Carlomagno, G., & Genazzani, A. D. (2015). Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecological Endocrinology, 31(2), 131–135. https://doi.org/10.3109/09513590.2014.964640
  • Kane, M. T., & Bavister, B. D. (1988). Vitamin requirements for development of eight-cell hamster embryos to hatching blastocysts in vitro. Biology of Reproduction, 39(5), 1137–1143. https://doi.org/10.1095/biolreprod39.5.1137
  • Kaneko, T., & Ohno, R. (2011). Improvement in the development of oocytes from C57BL/6 mice after sperm injection. Journal of the American Association for Laboratory Animal Science, 50(1), 33–36. https://www.ingentaconnect.com/contentone/aalas/jaalas/2011/00000050/00000001/art00005;jsessionid=1o0m0r4unuoik.x-ic-live-01
  • Khosla, S., Dean, W., Reik, W., & Feil, R. (2001). Culture of preimplantation embryos and its long-term effects on gene expression and phenotype. Human Reproduction Update, 7(4), 419–427. https://doi.org/10.1093/humupd/7.4.419
  • Korosi, T., Barta, C., Rokob, K., & Torok, T. (2017). Physiological Intra-Cytoplasmic Sperm Injection (PICSI) outcomes after oral pretreatment and semen incubation with myo-inositol in oligoasthenoteratozoospermic men: Results from a prospective, randomized controlled trial. European Review for Medical and Pharmacological Sciences, 21(2 Suppl), 66–72. https://www.europeanreview.org/article/12301
  • Kuşcu, N., Bizzarri, M., & Bevilacqua, A. (2016). Myo-inositol safety in pregnancy: From preimplantation development to newborn animals. International Journal of Endocrinology, 2016, 2413857. https://doi.org/10.1155/2016/2413857
  • Kwon, H. M., Yamauchi, A., Uchida, S., Preston, A., Garcia-Perez, A., Burg, M., & Handler, J. (1992). Cloning of the cDNa for a Na+/myo-inositol cotransporter, a hypertonicity stress protein. Journal of Biological Chemistry, 267(9), 6297–6301. https://doi.org/10.1016/S0021-9258(18)42695-6
  • Laganà, A. S., Vitagliano, A., Noventa, M., Ambrosini, G., & D’Anna, R. (2018). Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: A systematic review and meta-analysis of randomized controlled trials. Archives of Gynecology and Obstetrics, 298(4), 675–684. https://doi.org/10.1007/s00404-018-4861-y
  • Lane, M., & Gardner, D. K. (2007). Embryo culture medium: Which is the best? Best Practice & Research. Clinical Obstetrics & Gynaecology, 21(1), 83–100. https://doi.org/10.1016/j.bpobgyn.2006.09.009
  • Lesoine, B., & Regidor, P.-A. (2016). Prospective randomized study on the influence of myoinositol in PCOS women undergoing IVF in the improvement of oocyte quality, fertilization rate, and embryo quality. International Journal of Endocrinology, 2016, 4378507. https://doi.org/10.1155/2016/4378507
  • Lewin, L. M., Yannai, Y., Melmed, S., & Weiss, M. (1982). Myo-inositol in the reproductive tract of the female rat. The International Journal of Biochemistry, 14(2), 147–150. https://doi.org/10.1016/0020-711X(82)90154-9
  • Lewin, L. M., Yannai, Y., Sulimovici, S., & Kraicer, P. (1976). Studies on the metabolic role of myo-inositol. Distribution of radioactive myo-inositol in the male rat. The Biochemical Journal, 156(2), 375–380. https://doi.org/10.1042/bj1560375
  • Lim, K. T., Jang, G., Ko, K. H., Lee, W. W., Park, H. J., Kim, J. J., Lee, S. H., Hwang, W. S., Lee, B. C., & Kang, S. K. (2007). Improved in vitro bovine embryo development and increased efficiency in producing viable calves using defined media. Theriogenology, 67(2), 293–302. https://doi.org/10.1016/j.theriogenology.2006.07.011
  • Lisi, F., Carfagna, P., Oliva, M. M., Rago, R., Lisi, R., Poverini, R., Manna, C., Vaquero, E., Caserta, D., Raparelli, V., Marci, R., & Moscarini, M. (2012). Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: A pilot study. Reproductive Biology and Endocrinology, 10(1), 52. https://doi.org/10.1186/1477-7827-10-52
  • Lobo, R. A., & Carmina, E. (2000). The importance of diagnosing the polycystic ovary syndrome. Annals of Internal Medicine, 132(12), 989–993. https://doi.org/10.7326/0003-4819-132-12-200006200-00010
  • Lupo, P. J., Goldmuntz, E., & Mitchell, L. E. (2010). Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. Journal of Biomedicine & Biotechnology, 2010, 630940. https://doi.org/10.1155/2010/630940
  • Martin-Hidalgo, D., Bragado, M. J., Batista, A. R., Oliveira, P. F., & Alves, M. G. (2019). Antioxidants and male fertility: From molecular studies to clinical evidence. Antioxidants, 8(4), 89. https://doi.org/10.3390/antiox8040089
  • Mehlmann, L. M., & Kline, D. (1994). Regulation of intracellular calcium in the mouse egg: Calcium release in response to sperm or inositol trisphosphate is enhanced after meiotic maturation. Biology of Reproduction, 51(6), 1088–1098. https://doi.org/10.1095/biolreprod51.6.1088
  • Menichini, D., & Facchinetti, F. (2017). Myoinositol: Mechanisms of action and role in the treatment of metabolic diseases, infertility and polycystic ovary syndrome. Nutrafoods, 16, 147–151. https://www.nutrafoods.eu/index.php/nutra/article/view/83
  • Michell, R. H. (2008). Inositol derivatives: Evolution and functions. Nature Reviews. Molecular Cell Biology, 9(2), 151–161. https://doi.org/10.1038/nrm2334
  • Milewska, E. M., Czyzyk, A., Meczekalski, B., & Genazzani, A. D. (2016). Inositol and human reproduction. From cellular metabolism to clinical use. Gynecological Endocrinology, 32(9), 690–695. https://doi.org/10.1080/09513590.2016.1188282
  • Mohammadi, F., Ashrafi, M., Zandieh, Z., Najafi, M., Niknafs, B., Amjadi, F. S., & Haghighi, M. (2020). The effect of preincubation time and myo-inositol supplementation on the quality of mouse MII oocytes. Journal of Reproduction & Infertility, 21(4), 259–268. https://doi.org/10.18502/jri.v21i4.4330
  • Mohammadi, F., Varanloo, N., Nasrabadi, M. H., Vatannejad, A., Amjadi, F., Masroor, M. J., Bajelan, L., Mehdizadeh, M., Aflatoonian, R., & Zandieh, Z. (2019). Supplementation of sperm freezing medium with myoinositol improve human sperm parameters and protects it against DNA fragmentation and apoptosis. Cell and Tissue Banking, 20(1), 77–86. https://doi.org/10.1007/s10561-018-9731-0
  • Montanino-Oliva, M., Buonomo, G., Carra, M., Lippa, A., & Lisi, F. (2020). Myo-inositol impact on sperm motility in vagina and evaluation of its effects on foetal development. European Review for Medical and Pharmacological Sciences, 24(5), 2704–2709 https://doi.org/10.26355/eurrev_202003_20540
  • Montanino-Oliva, M., Minutolo, E., Lippa, A., Iaconianni, P., & Vaiarelli, A. (2016). Effect of myoinositol and antioxidants on sperm quality in men with metabolic syndrome. International Journal of Endocrinology, 2016, 1674950. https://doi.org/10.1155/2016/1674950
  • Murgia, F., Corda, V., Serrenti, M., Usai, V., Santoru, M. L., Hurt, K. J., Passaretti, M., Monni, M. C., Atzori, L., & Monni, G. (2020). Seminal fluid metabolomic markers of oligozoospermic infertility in humans. Metabolites, 10(2), 64. https://doi.org/10.3390/metabo10020064
  • Nestler, J. E., & Unfer, V. (2015). Reflections on inositol(s) for PCOS therapy: Steps toward success. Gynecological Endocrinology, 31(7), 501–505. https://doi.org/10.3109/09513590.2015.1054802
  • Nordio, M., Basciani, S., & Camajani, E. (2019). The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: Comparison with other ratios. European Review for Medical and Pharmacological Sciences, 23(12), 5512–5521 https://doi.org/10.26355/eurrev_201906_18223
  • Nowicka-Bauer, K., & Nixon, B. (2020). Molecular changes induced by oxidative stress that impair human sperm motility. Antioxidants, 9(2), 134. https://doi.org/10.3390/antiox9020134
  • Pacchiarotti, A., Carlomagno, G., Antonini, G., & Pacchiarotti, A. (2016). Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecological Endocrinology, 32(1), 69–73. https://doi.org/10.3109/09513590.2015.1101444
  • Paige, S. L., Osugi, T., Afanasiev, O. K., Pabon, L., Reinecke, H., & Murry, C. E. (2010). Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One, 5(6), e11134. https://doi.org/10.1371/journal.pone.0011134
  • Pallotti, F., Cargnelutti, F., Senofonte, G., Carlini, T., Faja, F., Paoli, D., & Lombardo, F. (2019). In vitro effects of myo-inositol on normokinetic human semen samples with nonlinear motility. European Review for Medical and Pharmacological Sciences, 23(23), 10557–10563. https://doi.org/10.26355/eurrev_201912_19697
  • Palmieri, M., & da Siena, V. S. C. (2016). Myoinositol: From gametes to embryonic development. Current Trends in Clinical Embriology, 3(1), 19–29. https://doi.org/10.11138/cce/2016.3.1.019
  • Palmieri, M., Papale, P., Della Ragione, A., Quaranta, G., Russo, G., & Russo, S. (2016). In vitro antioxidant treatment of semen samples in assisted reproductive technology: Effects of myo-inositol on nemaspermic parameters. International Journal of Endocrinology, 2016, 1–5. https://doi.org/10.1155/2016/2839041
  • Panner Selvam, M. K., Finelli, R., Agarwal, A., & Henkel, R. (2021). Evaluation of seminal oxidation-reduction potential in male infertility. Andrologia, 53(2), e13610. https://doi.org/10.1111/and.13610
  • Papaleo, E., Unfer, V., Baillargeon, J.-P., Fusi, F., Occhi, F., & De Santis, L. (2009). Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertility and Sterility, 91(5), 1750–1754. https://doi.org/10.1016/j.fertnstert.2008.01.088
  • Pesty, A., Avazeri, N., & Lefèvre, B. (1998). Nuclear calcium release by InsP3-receptor channels plays a role in meiosis reinitiation in the mouse oocyte. Cell Calcium, 24(4), 239–251. https://doi.org/10.1016/S0143-4160(98)90048-3
  • Poverini, R., Carlomagno, G., Lisi, R., Lisi, F., & Oliva, M. M. (2014). Improving IUI outcomes by adding myo-inositol to the semen preparation procedure. Fertility and Sterility, 102(3), e334. https://doi.org/10.1016/j.fertnstert.2014.07.1131
  • Prabhakar, P., Mahey, R., Gupta, M., Khadgawat, R., Kachhawa, G., Sharma, J. B., Vanamail, P., Kumari, R., & Bhatla, N. (2021). Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles – Randomized controlled trial. Gynecological Endocrinology, 37(4), 332–336. https://doi.org/10.1080/09513590.2020.1810657
  • Punt–van der Zalm, J., Hendriks, J., Westphal, J., Kremer, J., Teerenstra, S., & Wetzels, A. (2009). Toxicity testing of human assisted reproduction devices using the mouse embryo assay. Reproductive Biomedicine Online, 18(4), 529–535. https://doi.org/10.1016/S1472-6483(10)60130-7
  • Raffone, E., Rizzo, P., & Benedetto, V. (2010). Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecological Endocrinology, 26(4), 275–280. https://doi.org/10.3109/09513590903366996
  • Revelli, A., Delle Piane, L., Casano, S., Molinari, E., Massobrio, M., & Rinaudo, P. (2009). Follicular fluid content and oocyte quality: From single biochemical markers to metabolomics. Reproductive Biology and Endocrinology, 7, 40. https://doi.org/10.1186/1477-7827-7-40
  • Rizzo, P., Raffone, E., & Benedetto, V. (2010). Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. European Review for Medical and Pharmacological Sciences, 14(6), 555–561. https://www.europeanreview.org/article/780
  • Roberts, D., Brown, J., Medley, N., & Dalziel, S. R. (2017). Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. The Cochrane Database of Systematic Reviews, 3(3), CD004454. https://doi.org/10.1002/14651858.CD004454.pub3
  • Rubino, P., Palini, S., Chigioni, S., Carlomagno, G., Quagliariello, A., De Stefani, S., Baglioni, A., & Bulletti, C. (2015). Improving fertilization rate in ICSI cycles by adding myoinositol to the semen preparation procedures: A prospective, bicentric, randomized trial on sibling oocytes. Journal of Assisted Reproduction and Genetics, 32(3), 387–394. https://doi.org/10.1007/s10815-014-0401-2
  • Sacchi, S., Marinaro, F., Tondelli, D., Lui, J., Xella, S., Marsella, T., Tagliasacchi, D., Argento, C., Tirelli, A., Giulini, S., & La Marca, A. (2016). Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol. Reproductive Biology and Endocrinology, 14(1), 52. https://doi.org/10.1186/s12958-016-0189-2
  • Saleh, R., Assaf, H., Abd El Maged, W. M., Elsuity, M., & Fawzy, M. (2018). Increased cryo-survival rate in ejaculated human sperm from infertile men following pre-freeze in vitro myo-inositol supplementation. Clinical and Experimental Reproductive Medicine, 45(4), 177–182. https://doi.org/10.5653/cerm.2018.45.4.177
  • Santamaria, A., Giordano, D., Corrado, F., Pintaudi, B., Interdonato, M., Vieste, G. D., Benedetto, A. D., & D’Anna, R. (2012). One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. Climacteric, 15(5), 490–495. https://doi.org/10.3109/13697137.2011.631063
  • Santoro, M., Aquila, S., & Russo, G. (2021). Sperm performance in oligoasthenoteratozoospermic patients is induced by a nutraceuticals mix, containing mainly myo-inositol. Systems Biology in Reproductive Medicine, 67(1), 50–63. https://doi.org/10.1080/19396368.2020.1826067
  • Scarselli, F., Lobascio, A. M., Terribile, M., Casciani, V., Greco, P., Franco, G., Minasi, M. G., & Greco, E. (2016). Analysis of MYO-Inositol effect on spermatozoa motility, in hyper viscous ejaculates and in patients with grades II and III varicocele. Archivio Italiano di Urologia, Andrologia, 88(4), 279–283. https://doi.org/10.4081/aiua.2016.4.279
  • Schillaci, R., Mangione, D., Lo Monte, G., & Vassiliadis, A. (2012). Inositol supplementation and IVF outcome: Preliminary data. Italian Journal of Gynaecology and Obstetrics, 24(1), 38–44.
  • Stachecki, J. J., & Armant, D. R. (1996). Transient release of calcium from inositol 1,4,5-trisphosphate-specific stores regulates mouse preimplantation development. Development, 122(8), 2485–2496. https://doi.org/10.1242/dev.122.8.2485
  • Stambolic, V., Ruel, L., & Woodgett, J. R. (1996). Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Current Biology, 6(12), 1664–1669. https://doi.org/10.1016/S0960-9822(02)70790-2
  • Thomas, R. M., Nechamen, C. A., Mazurkiewicz, J. E., Ulloa-Aguirre, A., & Dias, J. A. (2011). The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2+) mobilization . Endocrinology, 152(4), 1691–1701. https://doi.org/10.1210/en.2010-1353
  • Unfer, V., Carlomagno, G., Papaleo, E., Vailati, S., Candiani, M., & Baillargeon, J.-P. (2014). Hyperinsulinemia alters myoinositol to d-chiroinositol ratio in the follicular fluid of patients with PCOS. Reproductive Sciences, 21(7), 854–858. https://doi.org/10.1177/1933719113518985
  • Van der Auwera, I., & D'Hooghe, T. (2001). Superovulation of female mice delays embryonic and fetal development. Human Reproduction, 16(6), 1237–1243. https://doi.org/10.1093/humrep/16.6.1237
  • Vartanyan, E., Tsaturova, K., Devyatova, E., Mikhaylyukova, A., Levin, V., Petuhova, N., Markin, A., & Steptsova, E. (2017). Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization. Gynecological Endocrinology, 33(sup1), 8–11. https://doi.org/10.1080/09513590.2017.1399699
  • Vazquez-Levin, M. H., & Verón, G. L. (2020). Myo-inositol in health and disease: Its impact on semen parameters and male fertility. Andrology, 8(2), 277–298. https://doi.org/10.1111/andr.12718
  • Voglmayr, J. K., & White, I. G. (1971). Synthesis and metabolism of myoinositol in testicular and ejaculated spermatozoa of the ram. Journal of Reproduction and Fertility, 24(1), 29–37. https://doi.org/10.1530/jrf.0.0240029
  • Warner, S., Conlon, F., & Kane, M. (2003). Inositol transport in preimplantation rabbit embryos: Effects of embryo stage, sodium, osmolality and metabolic inhibitors. Reproduction, 125(4), 479–493. https://doi.org/10.1530/rep.0.1250479
  • Wdowiak, A. (2016). Myoinositol improves embryo development in PCOS patients undergoing ICSI. International Journal of Endocrinology, 2016, 6273298. https://doi.org/10.1155/2016/6273298
  • Wiener-Megnazi, Z., Vardi, L., Lissak, A., Shnizer, S., Reznick, A. Z., Ishai, D., Lahav-Baratz, S., Shiloh, H., Koifman, M., & Dirnfeld, M. (2004). Oxidative stress indices in follicular fluid as measured by the thermochemiluminescence assay correlate with outcome parameters in in vitro fertilization. Fertility and Sterility, 82(Suppl 3), 1171–1176. https://doi.org/10.1016/j.fertnstert.2004.06.013
  • Willert, K., & Jones, K. A. (2006). Wnt signaling: Is the party in the nucleus? Genes & Development, 20(11), 1394–1404. https://doi.org/10.1101/gad.1424006
  • Zheng, X., Lin, D., Zhang, Y., Lin, Y., Song, J., Li, S., & Sun, Y. (2017). Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. Medicine, 96(49), e8842. https://doi.org/10.1097/MD.0000000000008842

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.